Viewing Study NCT02900716


Ignite Creation Date: 2025-12-26 @ 11:46 AM
Ignite Modification Date: 2026-02-24 @ 10:47 AM
Study NCT ID: NCT02900716
Status: COMPLETED
Last Update Posted: 2020-11-27
First Post: 2016-08-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas
Sponsor:
Organization: